Literature DB >> 1660743

Continuously active sodium channels in osteoblastic ROS 17/2.8 cells.

C Richter1, J Ferrier.   

Abstract

Cell-attached patch clamp experiments revealed 13-20 pS Na(+)-conducting channels active at normal resting potentials (-28 +/- 1 mV; +/- SEM; 7 cells) in the rat osteosarcoma cell line, ROS 17/2.8. These channels were not blocked by tetrodotoxin, Cd2+, verapamil, or nifedipine. Replacing all cations in the patch pipette except Ca2+ with tetraethylammonium (TEA+) abolishes channel activity; but adding TEA+ to a pipette solution containing only Na+ does not. Depolarization was not necessary to activate these channels, and the open times were much longer than the millisecond open times characteristic of Na+ channels in excitable cells. Current-voltage curves reconstructed from mean single channel currents and mean channel open times resemble L-type Ca2+ current-voltage curves obtained from whole-cell experiments, with current peaks shifted to resting or more hyperpolarized potentials. The voltage sensitivity of these channels has implications on membrane potential stability and on the hyperpolarizing membrane potential spiking activity exhibited by ROS 17/2.8 cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1660743     DOI: 10.1016/0169-6009(91)90110-l

Source DB:  PubMed          Journal:  Bone Miner        ISSN: 0169-6009


  2 in total

1.  A large-conductance (BK) potassium channel subtype affects both growth and mineralization of human osteoblasts.

Authors:  Neil C Henney; Bo Li; Carole Elford; Pablo Reviriego; Anthony K Campbell; Kenneth T Wann; Bronwen A J Evans
Journal:  Am J Physiol Cell Physiol       Date:  2009-09-23       Impact factor: 4.249

2.  Evaluation of therapeutic effects of astaxanthin on impairments in salivary secretion.

Authors:  Takashi Yamada; Koufuchi Ryo; Yoshinori Tai; Yoh Tamaki; Hiroko Inoue; Kenji Mishima; Kazuo Tsubota; Ichiro Saito
Journal:  J Clin Biochem Nutr       Date:  2010-06-22       Impact factor: 3.114

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.